22
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Since COVID‐19 took a strong hold around the globe causing considerable morbidity and mortality, a lot of effort was dedicated to manufacturing effective vaccines against SARS‐CoV‐2. Many questions have since been raised surrounding the safety of the vaccines, and a lot of media attention to certain side effects. This caused a state of vaccine hesitancy that may prove problematic in the global effort to control the virus. This review was undertaken with the aim of putting together all the reported cardiovascular and haematological events post COVID‐19 vaccination in published literature and to suggest possible mechanisms to explain these rare phenomena.

          Related collections

          Most cited references137

          • Record: found
          • Abstract: not found
          • Article: not found

          Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

            Coronavirus disease 2019 (COVID-19) has resulted in considerable morbidity and mortality worldwide since December 2019. However, information on cardiac injury in patients affected by COVID-19 is limited.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              mRNA vaccines — a new era in vaccinology

              mRNA vaccines represent a promising alternative to conventional vaccine approaches because of their high potency, capacity for rapid development and potential for low-cost manufacture and safe administration. However, their application has until recently been restricted by the instability and inefficient in vivo delivery of mRNA. Recent technological advances have now largely overcome these issues, and multiple mRNA vaccine platforms against infectious diseases and several types of cancer have demonstrated encouraging results in both animal models and humans. This Review provides a detailed overview of mRNA vaccines and considers future directions and challenges in advancing this promising vaccine platform to widespread therapeutic use.
                Bookmark

                Author and article information

                Contributors
                prp4005@qatar-med.cornell.edu
                dez2003@qatar-med.cornell.edu
                Journal
                J Cell Mol Med
                J Cell Mol Med
                10.1111/(ISSN)1582-4934
                JCMM
                Journal of Cellular and Molecular Medicine
                John Wiley and Sons Inc. (Hoboken )
                1582-1838
                1582-4934
                29 December 2021
                February 2022
                : 26
                : 3 ( doiID: 10.1111/jcmm.v26.3 )
                : 636-653
                Affiliations
                [ 1 ] Weill Cornell Medicine Qatar Doha Qatar
                [ 2 ] Department of Cardiovascular Medicine Cleveland Clinic Cleveland Ohio USA
                Author notes
                [*] [* ] Correspondence

                Dalia Zakaria, Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Al Luqta St. Ar‐Rayyan, P.O. Box 24144, Doha, Qatar.

                Email: dez2003@ 123456qatar-med.cornell.edu

                Author information
                https://orcid.org/0000-0003-1170-6722
                https://orcid.org/0000-0001-7128-2701
                https://orcid.org/0000-0002-8243-7438
                https://orcid.org/0000-0001-6283-1596
                https://orcid.org/0000-0001-9020-0038
                Article
                JCMM17137
                10.1111/jcmm.17137
                8817142
                34967105
                951678d0-cf77-4f15-9c3c-94db7178615b
                © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 05 December 2021
                : 26 September 2021
                : 09 December 2021
                Page count
                Figures: 7, Tables: 0, Pages: 18, Words: 14189
                Funding
                Funded by: Qatar National Library
                Categories
                Review
                Reviews
                Custom metadata
                2.0
                February 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.1 mode:remove_FC converted:05.02.2022

                Molecular medicine
                covid‐19,haemorrhage,myocardial infraction,myocarditis,myopericarditis,pericarditis,thrombocytopenia,thrombosis,vaccine

                Comments

                Comment on this article